FDA Office Of Drug Safety Director-Designate Is ODE III Deputy Raczkowski

FDA Office of Drug Safety Director-designate Victor Raczkowski, MD, brings hands-on experience with the application of risk-management techniques from the review of GlaxoSmithKline's Lotronex